Sarcoma  >>  pomalidomide  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pomalidomide / Generic mfg.
NCT02659930: Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

Active, not recruiting
1
62
US
liposomal doxorubicin, pomalidomide
National Cancer Institute (NCI)
Kaposi Sarcoma
01/26
01/28
NCT04902443: Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Recruiting
1
54
US
Pomalidomide, Nivolumab
National Cancer Institute (NCI)
Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas
12/25
12/26

Download Options